The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults
Abstract
CONTEXT: Previous studies have suggested that subclinical abnormalities in thyroid-stimulating hormone levels are associated with detrimental effects on the cardiovascular system. OBJECTIVE: To determine the relationship between baseline thyroid status and incident atrial fibrillation, incident cardiovascular disease, and mortality in older men and women not taking thyroid medication. DESIGN, SETTING, AND PARTICIPANTS: A total of 3233 US community-dwelling individuals aged 65 years or older with baseline serum thyroid-stimulating hormone levels were enrolled in 1989-1990 in the Cardiovascular Health Study, a large, prospective cohort study. MAIN OUTCOME MEASURES: Incident atrial fibrillation, coronary heart disease, cerebrovascular disease, cardiovascular death, and all-cause death assessed through June 2002. Analyses are reported for 4 groups defined according to thyroid function test results: subclinical hyperthyroidism, euthyroidism, subclinical hypothyroidism, and overt hypothyroidism. RESULTS: Individuals with overt thyrotoxicosis (n = 4) were excluded because of small numbers. Eighty-two percent of participants (n = 2639) had normal thyroid function, 15% (n = 496) had subclinical hypothyroidism, 1.6% (n = 51) had overt hypothyroidism, and 1.5% (n = 47) had subclinical hyperthyroidism. After exclusion of those with prevalent atrial fibrillation, individuals with subclinical hyperthyroidism had a greater incidence of atrial fibrillation compared with those with normal thyroid function (67 events vs 31 events per 1000 person-years; adjusted hazard ratio, 1.98; 95% confidence interval, 1.29-3.03). No differences were seen between the subclinical hyperthyroidism group and euthyroidism group for incident coronary heart disease, cerebrovascular disease, cardiovascular death, or all-cause death. Likewise, there were no differences between the subclinical hypothyroidism or overt hypothyroidism groups and the euthyroidism group for cardiovascular outcomes or mortality. Specifically, individuals with subclinical hypothyroidism had an adjusted hazard ratio of 1.07 (95% confidence interval, 0.90-1.28) for incident coronary heart disease. CONCLUSION: Our data show an association between subclinical hyperthyroidism and development of atrial fibrillation but do not support the hypothesis that unrecognized subclinical hyperthyroidism or subclinical hypothyroidism is associated with other cardiovascular disorders or mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A high TSH level within the normal range appears to be protective and has been shown to be associated with reduced mortality risk in older euthyroid individuals.149”
From Hypothyroidism (2024) · cites this paper as [149]
In the citing paper
“Cardiac AEs, including tachycardia, palpitations and atrial fibrillation, arise from increased myocardial oxygen consumption and enhanced β‐adrenergic sensitivity.”
From Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review (2026) · cites this paper as [6]
In the citing paper
“Cardiovascular symptoms are the most frequent indicators of mild thyroid hormone excess in the elderly, similar to overt hyperthyroidism [52,53] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [53]
In the citing paper
“A 2-to 3-fold increased risk of atrial fibrillation (AF) was associated with SHyper in elderly subjects in two large prospective studies [52,53] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [53]
In the citing paper
“An increased incidence of AF has also been observed in elderly persons with low serum TSH (0.1-0.5 mIU/l) with an HR of 1.6 (95% CI: 1.0-2.5)[52] and 1.85 (95% CI: 1.14-3.00)[53] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [53]
In the citing paper
“Contradicting this, two other studies included in this meta-analysis reported a non-significant decreased risk for stroke associated with SHyper [53,82] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [53]
In the citing paper
“Older patients with low TSH and higher fT4 have a higher prevalence and incidence of atrial fibrillation compared with euthyroid subjects (94–98)”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [94]
In the citing paper
“Trials of levothyroxine in SCH using surrogate markers have shown improvement in LV function, vascular endothelial function, atherogenic lipid particles, or cardiac mitochondrial function (4,91,105-108).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [105]
In the citing paper
“In addition, several studies of older patients have shown SCH to have either a protective or no impact on CV disease risk (103-105).”
From Thyroid Hormones and Cardiovascular Function and Diseases (2018) · cites this paper as [105]
In the citing paper
“these findings have not been reproduced by all studies (13, 17, 25, 26)”
From Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study (2016) · cites this paper as [13]
In the citing paper
“However, there is significant heterogeneity within the literature, with some large and well-conducted studies failing to reproduce these associations (13, 21), as well as unresolved questions about causality.”
From Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study (2016) · cites this paper as [13]
In the citing paper
“in cohort studies, subclinical hyperthyroidism or lower serum TSH have been associated with many involutional disease states including dementia, osteoporosis, AF, muscle weakness, low bone density, and fracture (12–14, 18, 20, 48, 49).”
From Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study (2016) · cites this paper as [13]
In the citing paper
“In contrast with subclinical hypothyroidism, many previous studies have shown that low serum TSH is associated with poor outcomes, either increased all-cause or vascular mortality, or AF (12–14, 17, 29, 36, 37).”
From Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study (2016) · cites this paper as [13]
In the citing paper
“It has widely been assumed that these associations are caused by subclinical hyperthyroidism with detrimental effects of excess thyroid hormone, for instance its proarrhythmic effect on the heart leading to AF, despite the fact that serum thyroid hormones are within reference range (1, 13–15, 29, 41, 42).”
From Serum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study (2016) · cites this paper as [13]
In the citing paper
“Some studies report increased overall mortality rates in SH subjects (374,379-383), especially older subjects, while others indicate no relation (384)(385)(386)(387).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [384]
In the citing paper
“Some other, smaller studies have reached similar conclusions (374,383), although other smaller studies have failed to find a correlation (380,381,384,386).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [384]
In the citing paper
“Sawin et al. (399) first reported a 2.8-fold increased risk of atrial fibrillation in SH subjects over age 60 years in 1994, and subsequent studies have confirmed that the risk of arrhythmias, particularly atrial fibrillation, is increased in SH (381,384,388,391,400,401).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [384]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Kumar, M. V. J., & Chippada, A. R. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Self-citationThe Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
Tunbridge, W. M. G., Evered, D. C., Hall, R., Appleton, D. R., BREWIS, M., CLARK, F., Evans, J. G., Young, E. T., Bird, T., & Smith, P. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01340.x · Cited by 2,665
The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey
Vanderpump, M. P. J., Tunbrldge, W. M. G., French, J. M., Appleton, D., Bates, D., Clark, F., Evans, J. G., Hasan, D. M., Rodgers, H., Tunbridge, F., et al. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01894.x · Cited by 2,432
Cited by
Sorted by citations
Items 401–500 of 860
Holley, M., Razvi, S., Farooq, M. S., Dew, R., Maxwell, I., & Wilkes, S. (2024) · Systematic Reviews · doi:10.1186/s13643-024-02548-7 · Cited by 17
Kerp, H., Hönes, G. S., Tolstik, E., Hönes-Wendland, J., Gassen, J., Moeller, L. C., Lorenz, K., & Führer, D. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.683522 · Cited by 15
“However, recent studies challenge this “one-for-all” concept (55–57) and have advocated a more risk-based TH treatment strategy in case of hypothyroidism (58, 59).”
BackgroundRuan, W., Zhou, X., Li, J., Wang, T., Liu, H., Zhang, G., & Lin, K. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.05.021 · Cited by 15
Wang, X., Wang, H., Yan, L., Yang, L., Xue, Y., Yang, J., Yao, Y., Tang, X., Tong, N., Wang, G., et al. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1101 · Cited by 17
“org 783 Age and sex stratified prevalence of hypertension in different SCH subgroups Several previous studies have found that SCH patients over 65 are less susceptible to adverse cardiovascular events than younger patients [17,22-24], and levothyroxine treatment does not help SCH patients over 65 years old [25].”
BackgroundSong, E., Kim, M., Park, S., Park, M., Kim, J. A., Roh, E., Yu, J. H., Kim, N. H., Seo, J. A., Kim, S. G., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.761782 · Cited by 15
Nacar, A. B., Acar, G., Yorgun, H., Akçay, A., Özkaya, M., Canpolat, U., Akkoyun, M., & Tuncer, C. (2012) · Echocardiography · doi:10.1111/j.1540-8175.2012.01718.x · Cited by 15
Geng, J., Lu, W., Hu, T., Tao, S., Zhang, H., Chen, J., Bu, Y., Ma, S., & Wang, B. (2014) · Endocrine · doi:10.1007/s12020-014-0472-y · Cited by 15
Izkhakov, E., Zahler, D., Rozenfeld, K.-L., Ravid, D., Banai, S., Topilsky, Y., Stern, N., Greenman, Y., & Shacham, Y. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123829 · Cited by 17
“Individuals with overt hypothyroidism reportedly have an increased risk of functional cardiovascular abnormalities and coronary artery disease, as well as accelerated atherosclerosis [5,6].”
BackgroundYang, L., Zou, J., Zhang, M., Xu, H. Y., Qi, W., Gao, L., & Zhao, J. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej12-0448 · Cited by 15
Subclinical Thyroid Dysfunction and the Heart
Cappola, A. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1575 · Cited by 15
Zaman, B. A., Rasool, S. O., Sabri, S. M., Raouf, G. A. M., Balatay, A. A., Abdulhamid, M. A., Hussein, D. S., Odisho, S. K., George, S. T., Hassan, S. M., et al. (2021) · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · doi:10.4081/jbr.2021.10067 · Cited by 16
Souza, D. S., Marques, L. P., Costa, A., Cruz, J. S., Rhana, P., Santos‐Miranda, A., Joviano‐Santos, J. V., Durço, A. O., de Vasconcelos, C. M. L., & Roman‐Campos, D. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120945 · Cited by 14
Subclinical Hyperthyroidism and Cardiovascular Disease
Kim, H. J., & McLeod, D. S. A. (2024) · Thyroid · doi:10.1089/thy.2024.0291 · Cited by 15
Myocardial perfusion and intima-media thickness in patients with subclinical hypothyroidism
Knapp, M., Lisowska, A., Sobkowicz, B., Tycińska, A., Sawicki, R., & Musiał, W. (2013) · Advances in Medical Sciences · doi:10.2478/v10039-012-0068-9 · Cited by 14
de Miranda, É. J. F. P., Bittencourt, M. S., Staniak, H. L., Pereira, A. C., Foppa, M., Santos, I. S., Lotufo, P. A., & Benseñor, I. M. (2017) · Clinical Endocrinology · doi:10.1111/cen.13393 · Cited by 14
Graves’ disease, multinodular goiter and subclinical hyperthyroidism
Lassen, P. B., Kyrilli, A., Lytrivi, M., & Corvilain, B. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.09.004 · Cited by 15
MorbiNet Study: Hypothyroidism Comorbidity Networks in the Adult General Population
Moratalla-Navarro, F., Moreno, V. R., López‐Simarro, F., & Aguado, A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa927 · Cited by 14
Subclinical Hypothyroidism in Geriatric Population and Its Association With Heart Failure
Panday, P., Franchini, A. P. A., Iskander, B., Anwer, F., Oliveri, F., Fotios, K., & Hamid, P. (2021) · Cureus · doi:10.7759/cureus.14296 · Cited by 16
“A study showed that even with medication treatment, there was no improvement in various cardiovascular risk factors; therefore, it recommended no need to screen or treat the geriatric population patients with subclinical hypothyroidism [10].”
BackgroundInfluentialLi, H., Murphy, T. A., Zhang, L., Huang, B. S., Veitla, V., Scherlag, B. J., Kem, D. C., & Yu, X. (2015) · Endocrinology · doi:10.1210/en.2015-1655 · Cited by 14
Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer
Gazdag, A., Nagy, E. V., Erdei, A., Bodor, M., Berta, E., Szabó, Z., & Jenei, Z. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0143-0 · Cited by 14
Kalra, S., Williams, A. K., Whitaker, R., Hossain, M., Curtis, G. L., Giles, M. S., Sinha, A., & Bastawrous, S. S. (2009) · Injury · doi:10.1016/j.injury.2009.10.013 · Cited by 14
Sarfo‐Kantanka, O., Sarfo, F. S., Ansah, E. O., & Kyei, I. (2018) · Journal of Diabetes Research · doi:10.1155/2018/4783093 · Cited by 14
Is There Any Relationship between TSH Levels and Prognosis in Acute Coronary Syndrome?
Soeiro, A. D. M., Araújo, V. A., Vella, J. P., Bossa, A. S., Biselli, B., Leal, T. D. C. A. T., Soeiro, M. C. F. D. A., Junior, C. V. S., Mueller, C. E., & de Oliveira, M. T. (2018) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20180019 · Cited by 14
Goumidi, L., Gauthier, K. C., Legry, V., Mayi, T. H., Houzet, A., Cottel, D., Montaye, M., Proust, C., Kee, F., Ferrières, J., et al. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.94 · Cited by 14
(Healthy) Ageing: Focus on Iodothyronines
de Lange, P., Cioffi, F., Silvestri, E., Moreno, M., Goglia, F., & Lanni, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140713873 · Cited by 14
Hormones and Cardiovascular Disease in Older Men
Yeap, B. B., & Flicker, L. A. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.12.004 · Cited by 15
Cardiovascular Consequences of Subclinical Thyroid Dysfunction: More Smoke but No Fire
Ladenson, P. W. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-11-200806030-00011 · Cited by 14
Outcomes and Management of Stressor-Associated Atrial Fibrillation
Haimovich, J. S., Kany, S., Ajufo, E. C., Andrade, J. G., Benjamin, E. J., Healey, J. S., Kirchhof, P. F., Lubitz, S. A., McIntyre, W. F., Rienstra, M., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.07.031 · Cited by 13
Abbey, E. J., McGready, J., Sokoll, L. J., Simonsick, E. M., & Mammen, J. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.858332 · Cited by 14
“It is not clear that this will be true, since lower FT4 has been associated with both better physical function (11) and better survival (12, 13) in those with euthyroid TSH levels.”
BackgroundManagement of thyroid dysfunction and thyroid nodules in the ageing patient
Martínez‐Montoro, J. I., Doulatram‐Gamgaram, V. K., Olveira, G., Valdés, S., & Fernández‐García, J. C. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.06.005 · Cited by 13
Yu, G., Liu, S. M., Song, C., Ma, Q., Chen, X., Jiang, Y., Duan, H., He, Y., Wang, D., Wan, H., et al. (2024) · European Thyroid Journal · doi:10.1530/etj-23-0130 · Cited by 13
Role of Thyroid Hormone in Neurodegenerative Disorders of Older People
Mooradian, A. D., & Haas, M. J. (2025) · Cells · doi:10.3390/cells14020140 · Cited by 16
Mahto, M., Chakraborthy, B., Gowda, S. H., Kaur, H., Vishnoi, G., & Lali, P. (2012) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0206-y · Cited by 14
Dysthyroidism and Chronic Heart Failure: Pathophysiological Mechanisms and Therapeutic Approaches
Rizzo, C., Gioia, M. I., Parisi, G., Triggiani, V., & Iacoviello, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_132 · Cited by 14
Subclinical thyroid function and cardiovascular events in patients with atrial fibrillation
Moutzouri, E., Lyko, C., Feller, M., Blum, M. R., Adam, L., Blum, S., Aeschbacher, S., Fischer, U., Roten, L., Giovane, C. D., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1442 · Cited by 14
Metformin-induced thyrotropin suppression is not associated with cardiac effects
Cappelli, C., Rotondi, M., Pirola, I., Agosti, B., Formenti, A. M., Cata, P. D., Salvetti, M., Chiovato, L., & Castellano, M. (2014) · HORMONES · doi:10.1007/bf03401339 · Cited by 14
Association of thyroid-stimulating hormone with lipid concentrations: an 11-year longitudinal study
Langén, V. L., Niiranen, T., Puukka, P. J., Sundvall, J., & Jula, A. (2016) · Clinical Endocrinology · doi:10.1111/cen.13151 · Cited by 13
Dhital, R., Basnet, S., & Poudel, D. R. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.08.035 · Cited by 13
Thyroid Dysfunction States and Incident Cardiovascular Events: The Tehran Thyroid Study
Tohidi, M., Derakhshan, A., Akbarpour, S., Amouzegar, A., Mehran, L., Baghbani‐Oskouei, A., Azizi, F., & Hadaegh, F. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-123039 · Cited by 13
Gender-specific associations between subclinical hypothyroidism and blood pressure in Chinese adults
Duan, Y., Wang, X., Peng, W. H., Feng, Y. Y., Tang, W., Wu, X., Mao, X., Bo, R., Li, W., Chen, J., et al. (2009) · Endocrine · doi:10.1007/s12020-009-9244-5 · Cited by 13
“For example, several authors reported that there was no correlation between SCH and hypertension in a population-based study [13, 14 ].”
BackgroundPrognostic implications of thyroid disease in patients with atrial fibrillation
Vasilopoulou, A., Patsiou, V., Bekiaridou, Α., Papazoglou, Α. S., Moysidis, D. V., Spaho, M., Zergioti, M., Kostakakis, D., Kyriakideli, M.-E., Lampropoulou, C.-I., et al. (2023) · Heart and Vessels · doi:10.1007/s00380-023-02341-x · Cited by 13
Kamiński, G., Dziuk, M., Szczepanek‐Parulska, E., Zybek‐Kocik, A., & Ruchała, M. (2016) · Endocrine · doi:10.1007/s12020-016-0877-x · Cited by 12
Thyroid Function, Reverse Triiodothyronine, and Mortality in Critically Ill Clinical Patients
da Silveira, C. D. G., Vasconcelos, F., de Moura, E. B., da Silveira, B. T., Amorim, F. F. P., Shintaku, L. S., de Santana, R. B., Argotte, P. L. P., da Silva, S. F., Maia, M. D. O., et al. (2021) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24001 · Cited by 12
Approach to the Patient With a Suppressed TSH
Praw, S. S., & Brent, G. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac635 · Cited by 13
Chen, Z., Sun, Y., Zhang, Y., He, Y., Chen, H., & Su, Y. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04281-0 · Cited by 12
A practical contemporary approach to decision-making on subclinical hypothyroidism
Sgarbi, J. A., & Ward, L. S. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000317 · Cited by 15
Abbey, E. J., McGready, J., Ferrucci, L., Simonsick, E. M., & Mammen, J. S. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17015 · Cited by 12
INTENZO, C. M., Jabbour, S., Miller, J. L., Ahmed, I., Furlong, K., Kushen, M. C., Kim, S. M., & Capuzzi, D. M. (2011) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e3182175477 · Cited by 12
“By contrast, in the cardiovascular health study of 3233 subjects over age 65, subclinical hyperthyroidism was associated with an increased risk of atrial fibrillation, but no increased risk of coronary or cerebrovascular disease, nor all-cause mortality.(20) FIGURE 8.”
ResultSubclinical thyroid disorders – Consequences and implications for treatment
Franklyn, J. A. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.012 · Cited by 12
Barasch, E., Gottdiener, J. S., Bůžková, P., Cappola, A. R., Shah, S. J., deFilippi, C. R., Gardin, J. M., & Kizer, J. R. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae001 · Cited by 11
Han, B., Wang, L., Wang, X., Huang, K. J., Shen, Y., Wang, Z., & Jing, T. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118781 · Cited by 11
A systematic review of subclinical hyperthyroidism guidelines: a remarkable range of recommendations
Ursem, S. R., Boelen, A., Bruinstroop, E., Elders, P. J. M., Gussekloo, J., Poortvliet, R. K. E., Heijboer, A. C., & den Elzen, W. P. J. (2024) · European Thyroid Journal · doi:10.1530/etj-24-0036 · Cited by 11
Lifestyle Interventions to Tackle Cardiovascular Risk in Thyroid Hormone Signaling Disorders
Rodolfi, S., Rurale, G., Marelli, F., Persani, L., & Campi, I. (2025) · Nutrients · doi:10.3390/nu17132053 · Cited by 12
“Despite an increased prevalence of risk factors for arrhythmias such as atherosclerosis, hypertension and myocardial stiffness, epidemiological studies fail to demonstrate an increased prevalence of AF in hypothyroid patients [32,33].”
Jung, H., Cho, J., Jang, H. M., Kim, Y. S., Kang, S., Yang, C. W., Kim, N., Choi, J., Park, S., Kim, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112760 · Cited by 11
Ferreira, M. M., Teixeira, P. D. F. D. S., Mansur, V. A., Reuters, V. S., Almeida, C. D. P., & Vaisman, M. (2010) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2010005000040 · Cited by 11
Shakoor, S. A. K. K. A., Hawkins, R., Kua, S. Y., Ching, M. E., & Dalan, R. (2014) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v43n10p506 · Cited by 11
Lassen, P. B., Kyrilli, A., Lytrivi, M., Patino, M. R., & Corvilain, B. (2016) · Clinical Endocrinology · doi:10.1111/cen.13237 · Cited by 11
Thyroid dysfunction and cardiovascular risk factors in Bulgarian adults
Shinkov, A. D., Borissovа, A.-M., Kovatcheva, R. D., Vlahov, J. D., Dakovska, L. N., Atanassova, I., Vukov, M., & Aslanova, N. (2013) · Open Medicine · doi:10.2478/s11536-013-0235-9 · Cited by 11
Pezeshki, B., Ahmadi, A., & Karimi, A. (2020) · Galen Medical Journal · doi:10.31661/gmj.v9i0.1592 · Cited by 11
Validation of a Decision Rule for Selective TSH Screening in Atrial Fibrillation
Bellew, S. D., Moman, R. N., Lohse, C. M., Hess, E. P., & Bellolio, F. (2015) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2014.11.23490 · Cited by 11
Update on Lipid Metabolism and Thyroid Disorders
Jin, T., & Teng, X. (2014) · Cited by 11
Pre-admission TSH levels predict long-term mortality in adults treated for hypothyroidism
Akirov, A., Shochat, T., Shechvitz, A., Shimon, I., Diker-Cohen, T., & Robenshtok, E. (2017) · Endocrine · doi:10.1007/s12020-017-1453-8 · Cited by 10
The role of the hypothalamic–pituitary–thyroid axis in thyroid cancer
Abaandou, L., Ghosh, R., & Kłubo-Gwieździńska, J. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00364-4 · Cited by 10
Tuliani, T. A., Shenoy, M. H., Belgrave, K., Deshmukh, A. J., Pant, S., Hilliard, A. A., & Afonso, L. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.04.022 · Cited by 10
Ding, X., Zhu, C., Li, R., Wu, L., Wang, Y., Hu, S., Liu, Y.-M., Zhao, F.-Y., Zhao, Y., Zhang, M., et al. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00703-y · Cited by 10
Low-Normal Free Thyroxine Confers Decreased Serum Bilirubin in Type 2 Diabetes Mellitus
Deetman, P. E., Kwakernaak, A. J., Bakker, S. J. L., & Dullaart, R. P. F. (2013) · Thyroid · doi:10.1089/thy.2013.0156 · Cited by 10
Subclinical hypothyroidism ups the risk of vascular complications in type 2 diabetes
Mohamed, G. A., & Elsayed, A. M. (2017) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2016.10.003 · Cited by 10
Hypothyreose – wann und wie behandeln?
Koehler, V. F., Reincke, M., & Spitzweg, C. (2018) · Der Internist · doi:10.1007/s00108-018-0438-x · Cited by 10
Chen, J., Zhou, W., Pan, F., Cui, W., Li, M., & Hu, Y. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0113 · Cited by 10
Cai, X.-Q., Tian, F., Han, T.-W., Shan, D., Liu, Y., Yin, W.-J., Jing, J., Xu, Q., & Chen, Y. (2018) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2018.08.007 · Cited by 10
Long-term cardiovascular and cerebrovascular morbidity in Israeli thyroid cancer survivors
Izkhakov, E., Meyerovitch, J., Barchana, M., Shacham, Y., Stern, N., & Keinan‐Boker, L. (2019) · Endocrine Connections · doi:10.1530/ec-19-0038 · Cited by 10
Impact of surgery versus medical management on cardiovascular manifestations in Graves disease
Elnahla, A., Attia, A. S., Khadra, H. S., Munshi, R., Shalaby, H., Lee, G. S., & Kandil, E. H. (2020) · Surgery · doi:10.1016/j.surg.2020.03.023 · Cited by 10
Thyroid Hormones in the Human Body: A review
Rajalakshmi, A. N., & Begam, F. (2021) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v11i5.5039 · Cited by 15
Giontella, A., Lotta, L. A., Overton, J. D., Baras, A., Sartorio, A., Minuz, P., Gill, D., Melander, O., & Fava, C. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121306 · Cited by 10
“Several Mendelian randomization studies, involving large-scale genetic consortia [13,33,34] and longitudinal studies [7,32,35], reported the associations between TSH or hyperthyroidism and atrial fibrillation in line with our results.”
Common Medical Illnesses that Affect Anesthesia and Their Anesthetic Management
Agarwal, R., Porter, M. H., & Obeid, G. (2013) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/j.coms.2013.03.001 · Cited by 10
Incidence of Subclinical Hypothyroidism in Renal Transplant Patients
Halilčević, A., Hodžić, E., Mešić, E., & Trnačević, S. (2015) · Materia Socio Medica · doi:10.5455/msm.2015.27.4-108-111 · Cited by 10
Zhou, B., Guo, Y., Wu, N., Zhu, C., Gao, Y., Qing, P., Li, X., Wang, Y., Liu, G., Dong, Q., et al. (2016) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2016.12.006 · Cited by 10
Thyroid Nodules and Cancer in the Elderly
Lechner, M. G., & Hershman, J. M. (2015) · Cited by 10
Li, R.-B., Yang, X., Zhang, J., Wang, D., Cui, X., Bai, L., Zhao, L., & Cui, W. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.902411 · Cited by 9
“In addition, in three prospective studies, a similar association between subclinical hyperthyroidism and AF was noted (11, 12, 14).”
BackgroundHypothyroidism and Heart Failure: Epidemiology, Pathogenetic Mechanisms & Therapeutic Rationale
Francois, J. C., Al‐Sadawi, M., Casillas, J. A., Botti, E., Soni, L., Ponse, D., Decamps, S., & McFarlane, S. I. (2020) · International Journal of Clinical Research & Trials · doi:10.15344/2456-8007/2020/146 · Cited by 10
The Propensity for Inducing Atrial Fibrillation: A Comparative Study on Old versus Young Rabbits
Li, H., Scherlag, B. J., Kem, D. C., Zillner, C., Male, S., Thirunavukkarasu, S., Shen, X., Benbrook, A., Pitha, J. V., Lazzara, R., et al. (2014) · Journal of Aging Research · doi:10.1155/2014/684918 · Cited by 9
NHG-Standaard Schildklieraandoeningen
Wessels, P., van Rijswijk, E., Boer, M. A., & van Lieshout, J. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6614-9_86 · Cited by 9
Kim, D. D. W., Young, S., & Cutfield, R. (2008) · PubMed · Cited by 9
Geng, J., Hu, T., Wang, B., Lu, W., & Ma, S. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.205 · Cited by 8
“Mild thyroid dysfunction is associated with adverse cardiovascular outcomes, including coronary heart disease (CHD) events [1–4], CHD deaths [4–6], heart failure [7,8], and atrial fibrillation (AF) [9–11].”
BackgroundResultInfluentialZhang, K., Wang, W., Zhao, S., Katz, S. D., Iervasi, G., Gerdes, A. M., & Tang, Y. (2018) · Clinical Cardiology · doi:10.1002/clc.22858 · Cited by 8
Muthukumar, S., Ravikumar, K., Dhalapathy, S., Gomathy, T., Umadevi, S., & Maruthupandian, D. (2018) · World Journal of Surgery · doi:10.1007/s00268-018-4571-4 · Cited by 8
Yu., A. B., Alekber, A., Elena, N. P., & Eugenia, O. (2012) · InTech eBooks · doi:10.5772/29331 · Cited by 10
Thyroid Dysfunction and Cardiovascular Events in Patients With Dysglycemia
Shah, R., Orlov, S., Paré, G., & Gerstein, H. C. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.01.007 · Cited by 8
Shi, G.-M., Xu, Q., Zhu, C.-Y., & Yang, Y.-L. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700235 · Cited by 8
Carotid integrated backscatter analysis in patients with subclinical hypothyroidism
Franzoni, F., Galetta, F., Fallahi, P., Tocchini, L., Braccini, L., Rossi, M., Carpi, A., Santoro, G., & Antonelli, A. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03035.x · Cited by 8
Reverter, J. L., & Colomé, E. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.09.007 · Cited by 8
Goichot, B., & Luca, F. (2011) · La Presse Médicale · doi:10.1016/j.lpm.2011.09.009 · Cited by 8
Sairaku, A., Nakano, Y., Uchimura, Y., Tokuyama, T., Kawazoe, H., Watanabe, Y., Matsumura, H., & Kihara, Y. (2016) · Endocrine Connections · doi:10.1530/ec-16-0012 · Cited by 8
Ahadiat, O., Higgins, S., Trodello, C., Talmor, G., Kokot, N., & Wysong, A. S. (2017) · Dermatologic Surgery · doi:10.1097/dss.0000000000001241 · Cited by 8
Subclinical Hypothyroidism: An Overlooked Cause of Atrial Fibrillation?
Kolettis, T. M., & Tsatsoulis, A. A. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.710 · Cited by 8
Lee, S. A., Choi, D., Kwon, J., Lee, D. W., & Park, E. (2019) · Medicine · doi:10.1097/md.0000000000018537 · Cited by 8
“Along with this trend, comorbidities including heart failure,([4]) atrial fibrillation,([5]) cardiovascular diseases,([6]) depression,([7]) and metabolic disorders([8]) have also increased.”
BackgroundBilgir, O., Bilgir, F., Topcuoglu, T., Çalan, M., & Çalan, Ö. G. (2013) · Endocrine · doi:10.1007/s12020-013-9993-z · Cited by 8
Is subclinical hypothyroidism associated with cardiovascular disease in the elderly?
Yamamoto, K., Nakano, Y., Soejima, Y., Suyama, A., Oguni, K., Hasegawa, K., & Otsuka, F. (2025) · Endocrine Connections · doi:10.1530/ec-24-0601 · Cited by 8
Trends in the use of thyroid diagnostics and treatments between 2008 and 2019 in Germany
Thiyagarajan, A., Koenen, N., Ittermann, T., Völzke, H., & Haug, U. (2024) · Scientific Reports · doi:10.1038/s41598-024-77896-4 · Cited by 7
“…among adults (≥ 35 years), and it further highlights the need for more frequent screening (i.e., done as a part of routine examination) among symptomatic and high-risk individuals (persons ≥ 60 years, with cardiovascular diseases, other systemic/ chronic diseases, family history) 13–15 .”
Tessnow, A. H., Gigliotti, B. J., Perkins, J. M., Schneiderman, C. P., Pinsky, B. W., Guo, D., Barger, B., Singh, V., Flores, O. A., & Wyne, K. L. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.12.004 · Cited by 7
Metadata
- Authors
- Cappola, A. R., Fried, L. P., Arnold, A. M., Danese, M. D., Kuller, L. H., Burke, G. L., Tracy, R. P., & Ladenson, P. W.
- Affiliations
- University of Pennsylvania Health System (US)
- Johns Hopkins University (US)
- University of Washington (US)
- University of Pittsburgh (US)
- Wake Forest University (US)
- University of Vermont (US)
- Corresponding author
- Cappola, Anne R.
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2006-03-01
- Volume
- 295
- Issue
- 9
- Pages
- 1033
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1965686740
- Cited by
- 862
- References
- 47
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 41 · 2023: 46 · 2022: 39 · 2021: 35 · 2020: 40 · 2019: 32 · 2018: 42 · 2017: 45 · 2016: 44 · 2015: 39 · 2014: 61 · 2013: 62 · 2012: 64
- FWCI
- 32.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health (n01hc085082-026, n01hc085081-021, n01hc085079-024, n01hc015103-009, n01hc085084-005, n01hc085085-011, n01hc085083-027, n01hc085080-026, n01hc085086-022, n01hc035129-010)
- National Institute on Aging (N01HC85079, N01 HC‐15103, N01‐HC‐35129, K23AG19161, N01‐HC‐85086, K23AG019161)
- National Heart, Lung, and Blood Institute (N01-HC-85081, N01HC85085, N01 HC085086, N01HC-85083, N01HC15103, N01 HC085079, N01HC85082, N01 HC85086, N01 HC035129, N01HC85080, N01 HC015103, N01-HC85079, N01-HC85084, N01HC35129)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- subclinical hypothyroidism, overt hypothyroidism, thyroid-stimulating hormone, atrial fibrillation, cardiovascular disease, coronary artery disease, cerebrovascular disease, cardiovascular mortality, all-cause mortality, older adults, thyroid function, Cardiovascular Health Study, sex differences, hormone replacement therapy
- MeSH terms
- Aged, Atrial Fibrillation, Cardiovascular Diseases, Female, Humans, Hyperthyroidism, Hypothyroidism, Male, Risk Factors, Thyroid Gland, Thyrotropin, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
